564 related articles for article (PubMed ID: 17325053)
1. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
Nie CQ; Bernard NJ; Schofield L; Hansen DS
Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
[TBL] [Abstract][Full Text] [Related]
2. Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response.
Wu JJ; Chen G; Liu J; Wang T; Zheng W; Cao YM
Parasitol Int; 2010 Jun; 59(2):232-41. PubMed ID: 20219695
[TBL] [Abstract][Full Text] [Related]
3. Regulatory CD4+ CD25+ Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria.
Vigário AM; Gorgette O; Dujardin HC; Cruz T; Cazenave PA; Six A; Bandeira A; Pied S
Int J Parasitol; 2007 Jul; 37(8-9):963-73. PubMed ID: 17350019
[TBL] [Abstract][Full Text] [Related]
4. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection.
Ryg-Cornejo V; Nie CQ; Bernard NJ; Lundie RJ; Evans KJ; Crabb BS; Schofield L; Hansen DS
Immunobiology; 2013 Feb; 218(2):263-71. PubMed ID: 22704523
[TBL] [Abstract][Full Text] [Related]
5. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
Blanc AL; Keswani T; Gorgette O; Bandeira A; Malissen B; Cazenave PA; Pied S
Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
[TBL] [Abstract][Full Text] [Related]
6. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.
Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z
Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
8. Limited role of CD4+Foxp3+ regulatory T cells in the control of experimental cerebral malaria.
Steeg C; Adler G; Sparwasser T; Fleischer B; Jacobs T
J Immunol; 2009 Dec; 183(11):7014-22. PubMed ID: 19890049
[TBL] [Abstract][Full Text] [Related]
9. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
10. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria.
Amante FH; Haque A; Stanley AC; Rivera Fde L; Randall LM; Wilson YA; Yeo G; Pieper C; Crabb BS; de Koning-Ward TF; Lundie RJ; Good MF; Pinzon-Charry A; Pearson MS; Duke MG; McManus DP; Loukas A; Hill GR; Engwerda CR
J Immunol; 2010 Sep; 185(6):3632-42. PubMed ID: 20720206
[TBL] [Abstract][Full Text] [Related]
12. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
[TBL] [Abstract][Full Text] [Related]
13. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC
J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747
[TBL] [Abstract][Full Text] [Related]
14. IL-12Rβ2 is essential for the development of experimental cerebral malaria.
Fauconnier M; Palomo J; Bourigault ML; Meme S; Szeremeta F; Beloeil JC; Danneels A; Charron S; Rihet P; Ryffel B; Quesniaux VF
J Immunol; 2012 Feb; 188(4):1905-14. PubMed ID: 22238458
[TBL] [Abstract][Full Text] [Related]
15. Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection.
Haque A; Best SE; Ammerdorffer A; Desbarrieres L; de Oca MM; Amante FH; de Labastida Rivera F; Hertzog P; Boyle GM; Hill GR; Engwerda CR
Eur J Immunol; 2011 Sep; 41(9):2688-98. PubMed ID: 21674481
[TBL] [Abstract][Full Text] [Related]
16. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium chabaudi AS: distinct CD4(+)CD25(+)Foxp3(+) regulatory T cell responses during infection in DBA/2 and BALB/c mice.
Wang GG; Chen G; Feng H; Liu J; Jiang YJ; Shang H; Cao YM
Parasitol Int; 2013 Feb; 62(1):24-31. PubMed ID: 22971347
[TBL] [Abstract][Full Text] [Related]
18. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection.
Findlay EG; Greig R; Stumhofer JS; Hafalla JC; de Souza JB; Saris CJ; Hunter CA; Riley EM; Couper KN
J Immunol; 2010 Aug; 185(4):2482-92. PubMed ID: 20631310
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium yoelii: distinct CD4(+)CD25(+) regulatory T cell responses during the early stages of infection in susceptible and resistant mice.
Wu Y; Wang QH; Zheng L; Feng H; Liu J; Ma SH; Cao YM
Exp Parasitol; 2007 Mar; 115(3):301-4. PubMed ID: 17084842
[TBL] [Abstract][Full Text] [Related]
20. Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection.
Abel S; Lückheide N; Westendorf AM; Geffers R; Roers A; Müller W; Sparwasser T; Matuschewski K; Buer J; Hansen W
J Immunol; 2012 Jun; 188(11):5467-77. PubMed ID: 22544931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
